Abstract
Background: We recently reported that eugenol exerted comparable cytotoxicity towards human normal and tumor cells. In the present study, we investigated the effect of eugenol on interleukin-8 (IL-8) production by IL-1β-stimulated oral cells. Materials and Methods: The viable cell number was determined by direct cell counting with a hemocytometer after trypsinization. IL-8 released into the culture medium was determined by enzyme-linked immunosorbent assay (ELISA). Results: IL-1β (5 ng/ml) induced two orders of magnitude higher production of IL-8 by human cultured cells than unstimulated cells. Upon IL-1β stimulation, both gingival fibroblasts (HGF) and periodontal ligament fibroblasts (HPLF) produced the greatest amounts of IL-8 (approximately 200-300 ng/ml), followed by pulp cells (HPCs) (approximately 40-50 ng/ml), whereas skin keratinocyte (HaCat) and oral squamous cell carcinoma cells (HSC-2, HSC-4) produced much less IL-8 (less than 15 ng/ml). The production of IL-8 depended on growth factor(s), since the omission of fetal bovine serum from the culture medium resulted in an approximately 90% decline of IL-8 production. Eugenol (5-500 μM) significantly stimulated IL-8 production in HGF cells, but had bi-modal effects on HPCs, causing slight stimulation at lower concentration (5 μM) and a significant inhibition at higher concentration (500 μM), regardless of the presence or absence of serum. Eugenol exerted similar effects on lipopolysaccharide-stimulated HGFs and HPCs. Conclusion: These results demonstrate that an anti-inflammatory effect of eugenol is observed in HPCs, but not in HGFs. The narrow therapeutic range of eugenol suggests the importance of careful usage of this compound for dental treatment.
- Received November 29, 2012.
- Revision received January 15, 2013.
- Accepted January 16, 2013.
- Copyright © 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved